NovaBridge Biosciences (NBP) Live Share Price, Invest From India

NovaBridge Biosciences Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$2.02
Day's Price Range
$2.09
$2.06
1.94%
Downside
1.46%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$2.06
100.00%
Downside
-100.00%
Upside

NovaBridge Biosciences share price movements today

Previous Close: $2.10
Open: $2.09
Volume: 877.4K
Day's Low - High: $2.02 - $2.09

NovaBridge Biosciences Historical Returns

1 Month Return: -11.02 %
3 Month Return: -35.19 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

NovaBridge Biosciences Stock Fundamentals & Key Indicators

Check NovaBridge Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$254.4M

EPS (TTM)

-0.94

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-40.89%

NovaBridge Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of NovaBridge Biosciences with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
NovaBridge Biosciences	NA	$254.4M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Indian Investors' Interest in NovaBridge Biosciences Stock

Search interest for NovaBridge Biosciences Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-5% versus previous 30 day period

NovaBridge Biosciences Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	3	1	-	-	-	-	-	-	-
Gross Profit	3	-19	-	-	-	-	-	0	-
Operating Income	-282	-90	-15	-12	-13	-5	-7	-8	-72
EBITDA	-275	-84	-103	-6	-	-5	-7	-8	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	0	0	-	-	0	0
Income Before Tax	-346	-69	-49	-20	-10	-3	-5	-6	-72
Income Tax Expense	-	-	-42	-	-	-	-	-	-
Net Income	-346	20	25	-20	-9	-3	-5	-6	-30
Net Profit Margin	-8673.15%	1835.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

NovaBridge Biosciences Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	11	53	30	1,542	13	-1	0	-	-
Gross Profit	11	53	30	1,542	6	-35	0	-	0
Operating Income	-280	-438	-1,464	155	-2,071	-366	-511	-375	-94
EBITDA	-279	-431	-197	168	-2,057	-51	-344	-373	-93
Interest Expense	0	1	0	0	-	0	0	-	-
Depreciation	-	-	-	-	5	1	1	0	0
Income Before Tax	-298	-401	-1,451	483	-2,332	-973	-1,465	-362	-88
Income Tax Expense	-	1	-	12	0	0	-1,258	-	-
Net Income	-298	-402	-1,485	470	-366	-359	-205	-162	-46
Net Profit Margin	-2580.82%	-749.02%	-4950.00%	30.53%	-2648.70%	23438.90%	-32674.02%	0.00%	0.00%

NovaBridge Biosciences Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	20	180	-143	-9	-22	-13	-48	-30	-72
Operating Cash Flow	-	-	8	-10	-	-	13	-14	-14
Investing Cash Flow	-	-	-	-	-	-	0	-	-
Financing Cash Flow	-	-	-	-	-	-	433	-3	-3
Change in Cash	-	-	-72	-11	-	-	446	-17	-17

NovaBridge Biosciences Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-402	-1,451	470	-2,331	-2,507	-208	-49	-88
Operating Cash Flow	-280	-867	433	-973	-1,102	-72	-52	-20
Investing Cash Flow	9	212	-201	-727	458	-107	-135	104
Financing Cash Flow	1,479	152	3,440	593	42	-8	0	57
Change in Cash	1,268	-487	3,565	-1,235	-212	-151	-233	142

Insights on NovaBridge Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NBP has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.4% return, outperforming this stock by 59.7%
NEGATIVE IMPACT
Price Dip
In the last 3 months, NBP stock has moved down by -34.6%

About NovaBridge Biosciences

NovaBridge Biosciences, a biotechnology company, focuses on the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. It is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; VIS-101, a bispecific antibody, which is in Phase 2b clinical trail for Wet AMD and other retinal diseases; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. The company has a strategic licensing agreement with AffaMed and AskGene to develop and commercialize VIS-101 to Visara. It also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

Organisation	NovaBridge Biosciences
Headquarters	2440 Research Boulevard, Rockville, MD, United States, 20850
Industry	Biotechnology
CEO	Dr. Xi-Yong Fu M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of NovaBridge Biosciences

Name	Title
Mr. Sean Wuxiong Cao M.B.A., Ph.D.	Chief Business Development Officer & Director
Mr. Tyler Ehler	Senior Director of Investor Relations
Dr. Phillip Dennis M.D., Ph.D.	Chief Medical Officer
Mr. Ming Lei	Chief Financial Officer
Dr. Xi-Yong Fu M.B.A., Ph.D.	CEO & Director
Mr. Mark Hagler	President & Chief Commercial Officer
Ms. Liwei Lin	General Counsel & Board Secretary
Dr. Cong Xu M.D., Ph.D.	Senior VP and Head of R&D Center of Excellence
Mr. Wei Fu	Executive Chairman

FAQs

What is NovaBridge Biosciences share price today?

NovaBridge Biosciences share price today is $2.06 as on May 13, 2026 at 1:29 am IST at the close of the market. NovaBridge Biosciences share today touched a day high of $2.09 and a low of $2.02.

What is the 52 week high and 52 week low for NovaBridge Biosciences share?

NovaBridge Biosciences share touched a 52 week high of $ on January 1, 1970 and a 52 week low of $ on January 1, 1970. NovaBridge Biosciences stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $2.06,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is NovaBridge Biosciences's market capitalisation today?

NovaBridge Biosciences market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in NovaBridge Biosciences Stock (NBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for NovaBridge Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NovaBridge Biosciences Shares that will get you 0.7282 shares as per NovaBridge Biosciences share price of $2.06 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy NovaBridge Biosciences Stock (NBP) from India?

Indian investors can start investing in NovaBridge Biosciences (NBP) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in NovaBridge Biosciences stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:40 am IST). Based on NovaBridge Biosciences share’s latest price of $2.06 as on May 13, 2026 at 1:29 am IST, you will get 4.8544 shares of NovaBridge Biosciences. Learn more about fractional shares .